Peter Finan
Directeur Général chez Adorx Therapeutics Ltd.
Provenance du réseau au premier degré de Peter Finan
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
University of Leeds
99
| College/University | Other Consumer Services | 99 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA.
33
| Subsidiary | Miscellaneous Commercial Services | 33 |
Keystone Symposia
 Keystone Symposia Miscellaneous Commercial ServicesCommercial Services Keystone Symposia operates as a catalyst for the advancement of biomedical and life sciences by connecting scientists within and across disciplines at conferences and workshops. The company was founded by C. Fred Fox in 1972 and is headquartered in Silverthorne, CO.
20
| Non-Profit Organization | Miscellaneous Commercial Services | 20 |
Epidarex Capital Partners LLC
 Epidarex Capital Partners LLC Investment ManagersFinance Epidarex Capital Partners LLC (Epidarex Capital) is a venture capital firm founded in 2010 by Kyparissia Sirinakisvin. The firm is headquartered in Bethesda, Maryland.
14
| Private Company | Investment Managers | 14 |
Enterprise Therapeutics Ltd.
 Enterprise Therapeutics Ltd. BiotechnologyHealth Technology Enterprise Therapeutics Ltd. operates as a drug discovery company that engages in the research and development of therapies for the treatment of respiratory diseases. It focuses on developing therapies for chronic obstructive pulmonary diseases, cystic fibrosis, and asthma. The company was founded by John Mervyn David Store in May 2014 and is headquartered in Falmer, the United Kingdom.
8
| Holding Company | Biotechnology | 8 |
Lunac Therapeutics Ltd.
 Lunac Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Lunac Therapeutics Ltd. engages in the identification and development of anticoagulants. The company was founded by Helen Philippou and Richard Foster on April 18, 2018 and is headquartered in Leeds, the United Kingdom.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Curve Therapeutics Ltd.
 Curve Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Curve Therapeutics Ltd. operates as a drug-discovery company. It engages on the development of innovative technologies to address undruggable disease-modifying targets, with an in-house focus on cancer. The company was founded in 2019 and is headquartered in London, the United Kingdom.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Topas Therapeutics GmbH
 Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Leucid Bio Ltd.
 Leucid Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Leucid Bio Ltd. is a clinical-stage biotechnology company based in London, UK. The British company develops novel, lateral car cell therapies for the treatment of refractory cancers, with a focus on developing next-generation cell therapies for the benefit of individuals with hard-to-treat solid tumors. The company's operations are based at Guys Hospital, enabling them to maintain a patient-centric focus. Leucid's goal is to develop CAR-T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers. Leucid was established to translate 20 years of Kings College research in the CAR-T field and is led by a highly experienced management team, including scientific founder John Maher. Filippo Joseph Petti has been the CEO of the company since 2023.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Eternygen GmbH
 Eternygen GmbH Pharmaceuticals: MajorHealth Technology Eternygen GmbH engages in the research and development of drugs. It develops new drugs for dietary-related metabolic diseases which include obesity, diabetes mellitus and fatty liver. The company was founded by Marco J. Janezic in June 2012 and is headquartered in Berlin, Germany.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Epsilogen Ltd.
 Epsilogen Ltd. Pharmaceuticals: MajorHealth Technology Epsilogen Ltd. engages in the development of immunoglobulin E (IgE) antibodies to treat cancer. The firm offers IGEG platform technology based on combining the power of IgE and Immunoglobulin G (IgG) antibody molecules. The company was founded by Sophia Karagiannis and James Spicer and is headquartered in London, United Kingdom.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Adorx Therapeutics Ltd.
 Adorx Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Adorx Therapeutics Ltd. provides biotechnology, health care and therapeutics services. The company is headquartered in Edinburgh, the United Kingdom.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Epidarex Exeed Ltd.
 Epidarex Exeed Ltd. Miscellaneous Commercial ServicesCommercial Services Epidarex Exeed Ltd. is a British biotechnology company that specializes in research and experimental development. The company is based in Edinburgh, UK. The company was founded in 2019 by Elizabeth Ann Roper and Henning Steinhagen, with Henning Steinhagen serving as the CEO since its inception.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Clyde Biosciences Ltd.
 Clyde Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Clyde Biosciences Ltd. provides developmental drug testing services. It offers drug screening, toxicity data analysis, direct measurements, and drug induced changes investigation services. Its services include calcium, voltage, contractility, in silico modeling, CiPA studies and bespoke R&D. The company was founded by Margaret Anne Craig, Godfrey Smith, Francis Burton, and Jon Cooper on March 9, 2012 and is headquartered in Glasgow, the United Kingdom.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Peter Finan via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
Caldan Therapeutics Ltd.
 Caldan Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Caldan Therapeutics Ltd. provides novel therapeutics targeting free fatty acid. It focuses on developing drugs in order to deliver anti-diabetic effects in multiple tissues and organs. The company was founded by Graeme Milligan and Trond Ulven and is headquartered in Edinburgh, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Corporate Officer/Principal Corporate Officer/Principal Graduate Degree | |
| Imperial College London | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
SIRAKOSS Ltd.
 SIRAKOSS Ltd. Medical SpecialtiesHealth Technology SIRAKOSS Ltd. develops medical devices. It focuses on synthetic Bone technology. The company was founded in October 2010 by Jordan Christopher Conway, Janet Mabel Scott Gibson, and Iain Ronald Gibson and is headquartered in Aberdeen, the United Kingdom. | Medical Specialties | Director/Board Member Director/Board Member | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Corporate Officer/Principal Founder | |
Edinburgh Molecular Imaging Ltd.
 Edinburgh Molecular Imaging Ltd. Medical SpecialtiesHealth Technology Edinburgh Molecular Imaging Ltd. develops optical molecular imaging technology, which includes optical imaging, cancer imaging and lung imaging. The firm's molecular imaging technology, based on Fluorescent Imaging, has the potential to detect disease in real-time during interventional procedures including surgery, providing more accurate treatment while sparing healthy tissue. The company was founded by Chris Haslett, Kev Dhaliwal and Mark Bradley in February 2014 and is headquartered in Edinburgh, the United Kingdom. | Medical Specialties | Director/Board Member Director/Board Member | |
| University of Sussex | College/University | Undergraduate Degree Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| The University of Edinburgh | College/University | Masters Business Admin Doctorate Degree | |
MASA Life Science Ventures
 MASA Life Science Ventures Investment ManagersFinance MASA Life Science Ventures (MASA Life Science Venture) is a venture capital firm founded in 1994 by Andrew Sinclair Dunlop. The firm is headquartered in Bethesda, Maryland. | Investment Managers | Private Equity Investor Private Equity Investor | |
Novartis Venture Funds (USA)
 Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | Investment Managers | Private Equity Investor Private Equity Investor | |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Virginia | College/University | Doctorate Degree Doctorate Degree | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Duke University Medical Center | College/University | Director/Board Member Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Mironid Ltd.
 Mironid Ltd. Pharmaceuticals: MajorHealth Technology Mironid Ltd. develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. The company was founded by Miles Houslay, Paul Barton Rodgers, Elizabeth Fairley, Julia Adam, David Adams and Nigel Pyne in 2014 and is headquartered in North Lanarkshire, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The Wellcome Trust Ltd.
 The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Investment Trusts/Mutual Funds | Director/Board Member Private Equity Analyst | |
| Georgetown University | College/University | Corporate Officer/Principal Undergraduate Degree | |
Sprout Group
 Sprout Group Investment ManagersFinance Sprout Group (Sprout) is venture capital subsidiary of Credit Suisse Private Equity LLC founded in 1969. The firm headquartered in New York. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Director/Board Member Chief Executive Officer | |
| Eberhard Karls Universität Tübingen | College/University | Corporate Officer/Principal Doctorate Degree | |
| EVOTEC SE | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Yale University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
Critical Path Institute
 Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Loughborough University | College/University | Doctorate Degree Undergraduate Degree | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Consultant / Advisor Corporate Officer/Principal | |
| University of Cambridge | College/University | Graduate Degree Doctorate Degree | |
Bill & Melinda Gates Foundation Trust
 Bill & Melinda Gates Foundation Trust Financial ConglomeratesFinance The Bill & Melinda Gates Foundation was formed in 1997 as the William H. Gates Foundation. In 1999, the foundation was renamed the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation Trust was created in January 2000 through the merger of the Gates Learning Foundation, which worked to expand access to technology through public libraries and the William H. Gates Foundation, which focused on improving global health. The foundation participates in preventive approaches and collaborative endeavors with government, philanthropic and not-for-profit partners. Priority is given to grants that leverage additional support and serve as a catalyst for long-term, systemic change. The foundation also provides funds to promote greater equity in global health, education and public libraries. Through their partnerships in communities across the US, the Bill & Melinda Gates Foundation is committed to raising the high school graduation rate and helping all students, regardless of race or family income. The foundation is headquartered in Seattle, Washington. | Financial Conglomerates | Director/Board Member Public Communications Contact | |
ELECSNET JSC
 ELECSNET JSC Miscellaneous Commercial ServicesCommercial Services ELECSNET JSC provides financial services online and through self-service terminals. It offers instant payments and money transfers, cash collection, as well as payment processing. The company was founded by Nikolay Vitalyevich Redko, Yuriy Ivanovich Lokotsov, Yuriy Valentinovich Maltsev, Sergey Konstantinovich Kuzin, and Konstantin Yuryevich Slashchev in 2000 and is headquartered in Moscow, Russia. | Miscellaneous Commercial Services | Director/Board Member | |
| FIRST KEYSTONE CORPORATION | Regional Banks | Corporate Officer/Principal | |
Deutsche Alternative Asset MGMT (UK) Ltd. (Private Equity)
 Deutsche Alternative Asset MGMT (UK) Ltd. (Private Equity) Investment ManagersFinance Deutsche Alternative Asset MGMT (UK) Ltd is a private equity subsidiary of Deutsche Alternative Asset Management (UK) Ltd. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
Isomerase Therapeutics Ltd.
 Isomerase Therapeutics Ltd. BiotechnologyHealth Technology Isomerase Therapeutics Ltd. operates as a drug discovery and development company. It specializes in biosynthetic medicinal chemistry and synthetic biology, microbial natural products, microbial natural products, and semisynthetic chemistry. The company was founded by Barrie Wilkinson, Matthew Gregory, and Steven Moss in 2012 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Founder | |
| Pomona Europe Advisers Ltd. | Investment Managers | Private Equity Analyst | |
Lansinoh Laboratories, Inc.
 Lansinoh Laboratories, Inc. Apparel/FootwearConsumer Non-Durables Lansinoh Laboratories, Inc. manufactures baby products. It offers AC adapter, ultimate protection disposable nursing, ComfortFit and extra pumping set. The company is headquartered in Alexandria, VA. | Apparel/Footwear | President | |
| University of Manchester Institute of Science & Technology | College/University | Undergraduate Degree | |
| City University London | College/University | Graduate Degree | |
| TBC BANK GROUP PLC | Major Banks | Corporate Officer/Principal | |
| TCS GROUP HOLDING PLC | Regional Banks | Chief Executive Officer | |
Tinkoff Private Breweries LLC
 Tinkoff Private Breweries LLC Beverages: AlcoholicConsumer Non-Durables Tinkoff Restaurants brews beer and operates a chain of restaurants. It manufactures and sells beer under the brand name Tinkoff. The firm also operates brewery-restaurants in Moscow, St. Petersburg, Samara, Kazan, Sochi, Ufa, Ekaterinburg, Togliatti, Nizhny Novgorod, Almaty, Rostov-on-Don, and Novosibirsk. The company was founded in 1998 and is headquartered in St. Petersburg, Russian Federation. | Beverages: Alcoholic | Chief Executive Officer | |
| HEADHUNTER GROUP PLC | Internet Software/Services | Director/Board Member | |
Keyhaven Capital Partners Ltd.
 Keyhaven Capital Partners Ltd. Investment ManagersFinance Keyhaven Capital Partners Ltd (Keyhaven Capital Partners) is an independent private equity firm founded in 2003 by Claus Stenbaek. The firm is headquartered in London, United Kingdom. | Investment Managers | Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 22 |
| Royaume-Uni | 19 |
| Russie | 5 |
| Allemagne | 4 |
| Suisse | 3 |
Sectorielle
| Consumer Services | 17 |
| Finance | 14 |
| Health Technology | 13 |
| Commercial Services | 5 |
| Consumer Non-Durables | 3 |
Opérationnelle
| Director/Board Member | 359 |
| Corporate Officer/Principal | 157 |
| Chairman | 61 |
| Chief Executive Officer | 52 |
| Undergraduate Degree | 47 |
Relations les plus connectées
| Insiders | |
|---|---|
| Paul Sekhri | 62 |
| Walter Moos | 30 |
| Henry Skinner | 29 |
| Amit Munshi | 27 |
| William Burns | 27 |
| Jeani Delagardelle | 26 |
| Bobby G. Soni | 23 |
| Kim Seng Teh | 20 |
| Maria Freire | 19 |
| Kyp Sirinakis | 19 |
| James Benfield | 19 |
| Mervyn Turner | 18 |
| Andrew Dunlop | 18 |
| Alexander Mayweg | 18 |
| Klaus Schollmeier | 17 |
- Bourse
- Insiders
- Peter Finan
- Connexions Sociétés
